Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC17195
Bax inhibitor peptide V5
BIP-V5; BAX Inhibiting Peptide V5
A Bax inhibitor -
GC16023
Bax inhibitor peptide P5
Bax inhibitor
-
GC12763
Bax channel blocker
Bax 通道阻滞剂是 BAX(一种凋亡调节剂)的选择性变构抑制剂。 Bax 通道阻滞剂直接与 BAX 结合并变构抑制 BAX 活化。 Bax 通道阻滞剂具有研究由 BAX 依赖性细胞死亡介导的疾病的潜力。
-
GC17131
Streptozocin
链脲佐菌素; Streptozotocin; U 9889
Streptozocin 是一种有效的 DNA 甲基化抗生素,是一种天然存在的亚硝基酰胺,在实验模型中广泛用于产生糖尿病。 -
GC10315
Plumbagin
白花丹素; 2-Methyljuglone
A natural naphthoquinone -
GC10282
Piperlongumine
荜茇酰胺; Piplartine
Piperlongumine是从Piper longum L.中提取的天然生物碱化合物,具有多种药理活性,包括抗肿瘤、脂质代谢调节、抗血小板聚集和镇痛活性等。 -
GC14860
Oncrasin 1
1-(4-氯苄基)-1H-吲哚-3-甲醛
An anticancer agent -
GC15484
Deguelin
鱼藤素; (-)-Deguelin; (-)-cis-Deguelin
A potent antiproliferative rotenoid compound -
GC17969
CHM 1
NSC656158
An inhibitor of tubulin polymerization -
GC16866
Actinomycin D
放线菌素D,DACTINOMYCIN
阿克替诺霉素D(也称为达克替诺霉素)是一种从链霉菌属中分离出来的天然色胺肽,含有一个杂环色团和两个五元环戊肽内酯环。 -
GC12258
2,3-DCPE hydrochloride
2,3-DCPE 是一种促凋亡化合物,对癌细胞\u003cem\u003e相对于\u003c/em\u003e正常人细胞具有选择性
-
GC16806
R18
PHCVPRDLSWLDLEANMCLP
R18 是 14-3-3 的肽拮抗剂,KD 为 70-90 nM。 R18 有效阻断 14-3-3 与激酶 Raf-1(14-3-3 的生理配体)的结合,并有效消除 14-3-3 对磷酸酶诱导的 Raf-1 失活的保护作用。 -
GC10258
Ac-IEPD-AFC
Ac-IEPD-AFC 是颗粒酶 B 的底物。
-
GC14886
PETCM
Α-(三氯甲基)-4-吡啶乙醇
PETCM 是 caspase-3 的激活剂,并以细胞色素 c (细胞 c) 依赖性方式发挥作用。 PETCM 促进 Apaf-1 寡聚化并诱导 HeLa 细胞中的细胞凋亡。 -
GC15364
L-685,458
L-685,458
A γ-secretase inhibitor -
GC18137
Ivachtin
Caspase-3 Inhibitor VII
A reversible caspase-3 inhibitor -
GC17255
Gliotoxin
胶霉毒素,Aspergillin
Gliotoxin是一种由病原性曲霉菌等真菌产生的免疫抑制性霉菌毒素,是一种特异性的20S蛋白酶体糜蛋白酶活性抑制剂,IC50为10μM。 -
GC10342
Calpeptin
A calpain inhibitor
-
GC13171
AZ 10417808
Caspase-3 inhibitor,selective non-peptide
-
GC10968
Ac-LEHD-AFC
A caspase-4, -5, and -9 fluorogenic substrate
-
GC15632
YM-155 hydrochloride
YM155 hydrochloride;YM 155 hydrochloride
A survivin inhibitor -
GC17386
YK-4-279
YK 4-279
YK-4-279 阻断 RNA Helicase A (RHA) 与 EWS-FLI1(致癌蛋白)的结合。 YK-4-279 诱导细胞凋亡并对各种癌细胞显示出抗增殖活性。 YK-4-279 有一个手性中心,它可以分成两种对映体。 YK-4-279可用于癌症研究。 -
GC14327
XL019
XL-019;XL 019
A potent, bioavailable JAK2 inhibitor -
GC11921
WEHI-539
WEHI539,WEHI 539
A selective Bcl-xL inhibitor -
GC14022
Voreloxin Hydrochloride
(3S-反式)-1,4-二氢-7-[3-甲氧基-4-(甲基氨基)-1-吡咯烷基]-4-氧代-1-(2-噻唑基)-1,8-萘啶-3-羧酸单盐酸盐,SNS-595 Hydrochloride; Vosaroxin Hydrochloride; AG 7352 Hydrochloride
Voreloxin Hydrochloride 是一流的拓扑异构酶 II 抑制剂,可嵌入 DNA 并诱导位点选择性 DNA DSB、G2 停滞和细胞凋亡。 -
GC13544
Voreloxin
SNS-595; Vosaroxin; AG 7352
An inhibitor of topoisomerase II -
GC16794
UNC1215
UNC 1215;UNC-1215
Potent L3MBTL3 domain inhibitor -
GC15272
Troglitazone
曲格列酮; CS-045
Selective PPARγ agonist -
GC14402
Triptolide
雷公藤甲素; PG490
雷公藤甲素(Triptolide)是一种二萜三环氧化物,首次从药用植物雷公藤 (Tripterygium wilfordii) 中分离出来,具有免疫抑制,抗炎,抗增殖和抗肿瘤作用。 -
GC18044
Trabectedin
曲贝替定; Ecteinascidin 743; ET-743
Trabectedin是一种具有强效抗肿瘤活性的四氢异喹啉生物碱。Trabectedin可选择性抑制与DNA损伤修复相关的转录因子,并阻断DNA核苷酸切除修复通路,导致DNA双链断裂和肿瘤细胞凋亡。Trabectedin还能调节肿瘤微环境,通过抑制肿瘤相关巨噬细胞的活性间接发挥抗肿瘤作用。Trabectedin常用于软组织肉瘤和卵巢癌的研究。 -
GC11298
TH-302
N,N'-双(2-溴乙基)二氨基膦酸(1-甲基-2-硝基-1H-咪唑-5-基)甲酯,TH 302,TH302,HAP-302,HAP302
A hypoxia-activated anticancer agent -
GC13984
Tamibarotene
他米巴罗汀; Am 80
A selective RARα agonist -
GC15307
SU5416
司马沙尼; SU5416; Semaxanib
SU5416 是一种有效的小分子血管内皮生长因子受体 (VEGFR) 抑制剂。 -
GC16371
Solasodine
澳洲茄铵,Purapuridine;Solancarpidine;Solasodin
An alkaloid with diverse biological activities -
GC16055
SMIP004
N-(4-丁基-2-甲基苯基)乙酰胺,SMIP 004;SMIP-004
SMIP004 是一种 SKP2 E3 连接酶抑制剂,可下调 SKP2 并稳定 p27。 SMIP004 是人前列腺癌细胞的癌细胞选择性凋亡诱导剂。 -
GC11455
Silvestrol
(1R,2R,3S,3AR,8BS)-6-[[(2S,3R,6R)-6-[(1R)-1,2-二羟基乙基]-3-甲氧基-1,4-二氧己环-2-基]氧基]-2,3,3A,8B-四氢-1,8B-二羟基-8-甲氧基-3A-(4-甲氧基苯基)-3-苯基-1H-环戊烯并[B]苯并呋喃-2-羧酸甲酯,(-)-Silvestrol
Silvestrol 是一种真核翻译起始因子 4A (eIF4A) 抑制剂,从 Agave americana Linn 中分离出来。Silvestrol 诱导自噬和半胱天冬酶介导的细胞凋亡。 -
GC10528
Salirasib
法尼基硫代水杨酸; S-Farnesylthiosalicylic acid; Farnesyl Thiosalicylic Acid; FTS
A Ras inhibitor with anti-cancer and anti-atherogenic activity -
GC18107
Salinomycin sodium salt
盐霉素钠; Salinomycin sodium; Sodium salinomycin
A selective cancer stem cell inhibitor -
GC14882
Salinomycin
盐霉素; Procoxacin
A selective cancer stem cell inhibitor -
GC11594
RG7388
RG 7388; RG-7388; ldasanutlin; Ro 5503781
An inhibitor of the MDM2-p53 interaction -
GC13019
RG7112
[(4R,5S)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧基苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基][4-[3-(甲磺酰基)丙基]-1-哌嗪基]甲酮,RG-7112;RG 7112
An inhibitor of the MDM2-p53 interaction -
GC14534
Regorafenib monohydrate
瑞格非尼一水合物,BAY 73-4506 monohydrate
A multi-kinase inhibitor -
GC14606
Regorafenib hydrochloride
瑞戈非尼盐酸盐; BAY 73-4506 hydrochloride
A multi-kinase inhibitor -
GC12857
R1530
5-(2-氯苯基)-7-氟-1,2-二氢-8-甲氧基-3-甲基吡唑并[3,4-B][1,4]苯并二氮杂卓,R 1530;R-1530
A multi-kinase inhibitor -
GC10171
Puromycin aminonucleoside
氨基核苷嘌呤霉素; NSC 3056
A glomerular epithelial cell toxin
-
GC15164
PND-1186
SR-2516;PND 1186;PND1186;SR 2516;SR2516; VS-4718; VS 4718; VS4718
A potent FAK inhibitor -
GC17214
PF-3758309
PF 3758309; PF3758309
An inhibitor of PAK4 -
GC17694
Pemetrexed disodium hemipenta hydrate
培美曲塞二钠水合物; LY231514 disodium hemipenta hydrate
Pemetrexed disodium hemipenta hydrate 是一种新型抗叶酸剂,LY231514 的五谷氨酸的 Ki 值分别为 1.3、7.2 和 65 nM,用于抑制胸苷酸合酶 (TS)、二氢叶酸还原酶 (DHFR) 和甘氨酰胺核糖核苷酸甲酰转移酶 (GARFT)。 -
GC10470
Nutlin-3a chiral
Nutlin-3a;Nutlin 3a
Nutlin-3a 手性是 Nutlin-3 的活性异构体,是鼠类双微体 2 (MDM2) 拮抗剂,IC50 值为 0.09μM。 -
GC11167
Necrostatin 2
(5R)-5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮,MTH-DL-Tryptophan, Necroptotic Inhibitor
A potent inhibitor of necroptosis